Annual CFF
$34.54 M
+$34.42 M+27754.44%
31 December 2023
Summary:
Bellevue Life Sciences Acquisit annual cash flow from financing activities is currently $34.54 million, with the most recent change of +$34.42 million (+27754.44%) on 31 December 2023. During the last 3 years, it has risen by +$34.60 million (+60273.34%). BLACU annual CFF is now at all-time high.BLACU Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$270.00 K
+$15.94 M+101.72%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit quarterly cash flow from financing activities is currently $270.00 thousand, with the most recent change of +$15.94 million (+101.72%) on 30 September 2024. Over the past year, it has increased by +$70.00 thousand (+35.00%). BLACU quarterly CFF is now -99.62% below its all-time high of $70.48 million, reached on 01 March 2023.BLACU Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$51.39 M
+$70.00 K+0.14%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit TTM cash flow from financing activities is currently -$51.39 million, with the most recent change of +$70.00 thousand (+0.14%) on 30 September 2024. Over the past year, it has dropped by -$122.13 million (-172.65%). BLACU TTM CFF is now -172.65% below its all-time high of $70.74 million, reached on 30 September 2023.BLACU TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLACU Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | +35.0% | -172.7% |
| 3 y3 years | +10000.0% | - | - |
| 5 y5 years | - | - | - |
BLACU Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -99.6% | +100.8% | -172.7% | +0.1% |
| 5 y | 5 years | at high | >+9999.0% | -99.6% | +100.8% | -172.7% | +0.1% |
| alltime | all time | at high | >+9999.0% | -99.6% | +100.8% | -172.7% | +0.1% |
Bellevue Life Sciences Acquisit Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $270.00 K(-101.7%) | -$51.39 M(-0.1%) |
| June 2024 | - | -$15.67 M(<-9900.0%) | -$51.46 M(+43.8%) |
| Mar 2024 | - | $150.00 K(-100.4%) | -$35.79 M(-203.6%) |
| Dec 2023 | $34.54 M | -$36.14 M(<-9900.0%) | $34.54 M(-51.2%) |
| Sept 2023 | - | $200.00 K(>+9900.0%) | $70.74 M(+0.3%) |
| June 2023 | - | $0.00(-100.0%) | $70.53 M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $70.48 M(>+9900.0%) | $70.59 M(>+9900.0%) |
| Dec 2022 | $124.00 K(-316.0%) | - | - |
| Dec 2022 | - | $56.60 K(-722.0%) | $124.00 K(+84.0%) |
| Sept 2022 | - | -$9100.00(-114.1%) | $67.40 K(-11.9%) |
| June 2022 | - | $64.70 K(+448.3%) | $76.50 K(+548.3%) |
| Mar 2022 | - | $11.80 K | $11.80 K |
| Dec 2021 | -$57.40 K | - | - |
FAQ
- What is Bellevue Life Sciences Acquisit annual cash flow from financing activities?
- What is the all time high annual CFF for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit annual CFF year-on-year change?
- What is Bellevue Life Sciences Acquisit quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly CFF year-on-year change?
- What is Bellevue Life Sciences Acquisit TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit TTM CFF year-on-year change?
What is Bellevue Life Sciences Acquisit annual cash flow from financing activities?
The current annual CFF of BLACU is $34.54 M
What is the all time high annual CFF for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high annual cash flow from financing activities is $34.54 M
What is Bellevue Life Sciences Acquisit annual CFF year-on-year change?
Over the past year, BLACU annual cash flow from financing activities has changed by +$34.42 M (+27754.44%)
What is Bellevue Life Sciences Acquisit quarterly cash flow from financing activities?
The current quarterly CFF of BLACU is $270.00 K
What is the all time high quarterly CFF for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high quarterly cash flow from financing activities is $70.48 M
What is Bellevue Life Sciences Acquisit quarterly CFF year-on-year change?
Over the past year, BLACU quarterly cash flow from financing activities has changed by +$70.00 K (+35.00%)
What is Bellevue Life Sciences Acquisit TTM cash flow from financing activities?
The current TTM CFF of BLACU is -$51.39 M
What is the all time high TTM CFF for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high TTM cash flow from financing activities is $70.74 M
What is Bellevue Life Sciences Acquisit TTM CFF year-on-year change?
Over the past year, BLACU TTM cash flow from financing activities has changed by -$122.13 M (-172.65%)